7,691 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Bought by Calton & Associates Inc.

Calton & Associates Inc. bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 7,691 shares of the medical equipment provider's stock, valued at approximately $3,809,000.

Other hedge funds have also modified their holdings of the company. Hurley Capital LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $28,000. Parvin Asset Management LLC purchased a new position in Intuitive Surgical during the fourth quarter worth approximately $26,000. Chilton Capital Management LLC lifted its position in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after buying an additional 43 shares in the last quarter. Global Financial Private Client LLC raised its position in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the period. Finally, Elite Financial Inc. purchased a new stake in Intuitive Surgical in the first quarter valued at $26,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of the business's stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the transaction, the executive vice president owned 2,245 shares in the company, valued at $1,152,089.10. The trade was a 43.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director owned 6,371 shares in the company, valued at $3,312,920. This trade represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Up 0.5%

ISRG stock traded up $2.46 during trading on Friday, reaching $518.62. 1,903,997 shares of the company's stock were exchanged, compared to its average volume of 1,666,315. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company's fifty day moving average price is $535.90 and its 200-day moving average price is $536.21. The firm has a market cap of $185.88 billion, a PE ratio of 76.04, a P/E/G ratio of 5.50 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the previous year, the business earned $1.50 EPS. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of research reports. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th. BTIG Research set a $566.00 price objective on Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, July 14th. Piper Sandler cut their price target on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Barclays dropped their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Finally, Truist Financial dropped their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $592.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.